Axa’s Crescent Biopharma, Inc. Common Stock CBIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-15,877
| Closed | -$4.76M | – | 1093 |
|
|
2024
Q1 | $4.76M | Buy |
15,877
+4
| +0% | +$1.2K | 0.01% | 566 |
|
|
2023
Q4 | $3.75M | Sell |
15,873
-384
| -2% | -$90.6K | 0.01% | 611 |
|
|
2023
Q3 | $2.44M | Sell |
16,257
-58
| -0.4% | -$8.7K | 0.01% | 673 |
|
|
2023
Q2 | $2.84M | Buy |
16,315
+224
| +1% | +$39K | 0.01% | 663 |
|
|
2023
Q1 | $2.03M | Buy |
+16,091
| New | +$2.03M | 0.01% | 761 |
|
|
2020
Q2 | – | Sell |
-306
| Closed | -$70K | – | 1256 |
|
|
2020
Q1 | $70K | Sell |
306
-9,146
| -97% | -$2.09M | ﹤0.01% | 1150 |
|
|
2019
Q4 | $5M | Buy |
9,452
+323
| +4% | +$171K | 0.02% | 620 |
|
|
2019
Q3 | $3.93M | Sell |
9,129
-177
| -2% | -$76.3K | 0.02% | 720 |
|
|
2019
Q2 | $11.1M | Buy |
9,306
+55
| +0.6% | +$65.6K | 0.04% | 447 |
|
|
2019
Q1 | $11.5M | Buy |
9,251
+159
| +2% | +$198K | 0.05% | 423 |
|
|
2018
Q4 | $8.61M | Buy |
9,092
+1,834
| +25% | +$1.74M | 0.04% | 462 |
|
|
2018
Q3 | $10.5M | Buy |
7,258
+1,129
| +18% | +$1.63M | 0.04% | 472 |
|
|
2018
Q2 | $9.89M | Buy |
6,129
+1,043
| +21% | +$1.68M | 0.04% | 455 |
|
|
2018
Q1 | $8.26M | Sell |
5,086
-24
| -0.5% | -$39K | 0.03% | 512 |
|
|
2017
Q4 | $8.58M | Buy |
+5,110
| New | +$8.58M | 0.03% | 516 |
|